Gilead combo HIV pill matches Truvada efficacy but safer in trial
September 02, 2015 at 09:39 AM EDT
Sept 1 (Reuters) - Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function.